Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in the development of anti-tumor agents due to its ability to modulate signaling pathways in malignant cells. Also employed in the study of apoptosis induction in leukemia and solid tumor models. Investigated for use in targeted therapies where selective inhibition of abnormal protein kinases is required. Its structural features support binding to ATP pockets in kinase domains, enhancing specificity and inhibitory activity.